BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3899194)

  • 1. Photochemotherapy using pyridopsoralens.
    Dubertret L; Averbeck D; Bisagni E; Moron J; Moustacchi E; Billardon C; Papadopoulo D; Nocentini S; Vigny P; Blais J
    Biochimie; 1985; 67(3-4):417-22. PubMed ID: 3899194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationship between lesions photoinduced by mono- and bi-functional furocoumarins in DNA and genotoxic effects in diploid yeast.
    Averbeck D
    Mutat Res; 1985 Sep; 151(2):217-33. PubMed ID: 3897850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A reappraisal of the use of 5-methoxypsoralen in the therapy of psoriasis.
    Calzavara-Pinton P; Ortel B; Carlino A; Honigsmann H; De Panfilis G
    Exp Dermatol; 1992 Jul; 1(1):46-51. PubMed ID: 1344660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genotoxic effects and DNA photoadducts induced in Chinese hamster V79 cells by 5-methoxypsoralen and 8-methoxypsoralen.
    Papadopoulo D; Averbeck D
    Mutat Res; 1985 Sep; 151(2):281-91. PubMed ID: 4033682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DNA photobinding of 7-methylpyrido[3,4-c]psoralen and 8-methoxypsoralen. Effects on macromolecular synthesis, repair and survival in cultured human cells.
    Nocentini S
    Mutat Res; 1986 Jul; 161(2):181-92. PubMed ID: 3724772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic effects of DNA mono- and diadducts photoinduced by furocoumarins in eukaryotic cells.
    Averbeck D; Papadopoulo D
    IARC Sci Publ; 1986; (70):299-312. PubMed ID: 3539789
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lethal and mutagenic effects photoinduced in haploid yeast (Saccharomyces cerevisiae) by two new monofunctional pyridopsoralens compared to 3-carbethoxypsoralen and 8-methoxypsoralen.
    Averbeck D; Averbeck S; Bisagni E; Moron L
    Mutat Res; 1985; 148(1-2):47-57. PubMed ID: 3881661
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenic effects of 3-carbethoxypsoralen and 8-methoxypsoralen plus 365-nm irradiation in mammalian cells.
    Papadopoulo D; Sagliocco F; Averbeck D
    Mutat Res; 1983 Dec; 124(3-4):287-97. PubMed ID: 6656829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of sister chromatid exchanges and gene mutations in Chinese hamster ovary cells by psoralens.
    Loveday KS; Donahue BA
    Natl Cancer Inst Monogr; 1984 Dec; 66():149-55. PubMed ID: 6531021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bath-5-methoxypsoralen-UVA therapy for psoriasis.
    Calzavara-Pinton PG; Zane C; Carlino A; De Panfilis G
    J Am Acad Dermatol; 1997 Jun; 36(6 Pt 1):945-9. PubMed ID: 9204060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of 8-methoxypsoralen vs. 5-methoxypsoralen plus ultraviolet A therapy in patients with mycosis fungoides.
    Wackernagel A; Hofer A; Legat F; Kerl H; Wolf P
    Br J Dermatol; 2006 Mar; 154(3):519-23. PubMed ID: 16445785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An intraindividual comparative study of psoralen-UVA erythema induced by bath 8-methoxypsoralen and 4, 5', 8-trimethylpsoralen.
    Man I; McKinlay J; Dawe RS; Ferguson J; Ibbotson SH
    J Am Acad Dermatol; 2003 Jul; 49(1):59-64. PubMed ID: 12833009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Problems posed by the therapeutic use of photosensitizers in dermatology].
    Beani JC; Amblard P; Reymond JL
    Biochimie; 1986 Jun; 68(6):905-12. PubMed ID: 2944547
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Photochemotherapy (PUVA) of psoriasis using 3-carbethoxypsoralen, a non-carcinogenic compound in mice.
    Dubertret L; Averbeck D; Zajdela F; Bisagni E; Moustacchi E; Touraine R; Latarjet R
    Br J Dermatol; 1979 Oct; 101(4):379-89. PubMed ID: 389271
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction in human skin fibroblasts of sister-chromatid exchanges (SCEs) by photoaddition of two new monofunctional pyridopsoralens in comparison to 3-carbethoxypsoralen and 8-methoxypsoralen.
    Billardon C; Levy S; Moustacchi E
    Mutat Res; 1984 Oct; 138(1):63-70. PubMed ID: 6493264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Photoinactivation and recovery in skin fibroblasts after formation of mono- and bifunctional adducts by furocoumarins-plus-UVA.
    Pohl J; Christophers E
    J Invest Dermatol; 1980 Oct; 75(4):306-10. PubMed ID: 7430696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary intake and risk assessment of phototoxic furocoumarins in humans.
    Schlatter J; Zimmerli B; Dick R; Panizzon R; Schlatter C
    Food Chem Toxicol; 1991 Aug; 29(8):523-30. PubMed ID: 1894218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photochemotherapy (PUVA) and psoriasis: comparison of 8-MOP and 8-MOP/5-MOP.
    Langner A; Wolska H; Kowalski J; Duralska H; Murawska E
    Int J Dermatol; 1976 Nov; 15(9):688-9. PubMed ID: 977210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of psoriasis with a new micronized 5-methoxypsoralen tablet and UVA radiation.
    Aubin F; Makki S; Humbert P; Muret P; Agache P
    Arch Dermatol Res; 1994; 286(1):30-4. PubMed ID: 8141609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of DNA-psoralen photoadducts in mammalian skin.
    Pathak MA; Zarebska Z; Mihm MC; Jarzabek-Chorzelska M; Chorzelski T; Jablonska S
    J Invest Dermatol; 1986 Mar; 86(3):308-15. PubMed ID: 2427607
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.